177 related articles for article (PubMed ID: 35463665)
1. Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis.
Lv X; Yin L; Wu W; Li N; Zhang R; Li X; Jia Q; Tan J; Wang P; Zheng X; He X; Huang C; Li D; Wang Y; Meng Z
J Healthc Eng; 2022; 2022():7640405. PubMed ID: 35463665
[TBL] [Abstract][Full Text] [Related]
2. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.
Upadhyaya A; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Zhou P; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z
Medicine (Baltimore); 2017 Jun; 96(25):e7164. PubMed ID: 28640094
[TBL] [Abstract][Full Text] [Related]
3. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
Upadhyaya A; Zhou P; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z; Wang X; Zhang X; Zhang W
Nucl Med Commun; 2017 Nov; 38(11):891-903. PubMed ID: 28806348
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.
Raza H; Khan AU; Hameed A; Khan A
Nucl Med Commun; 2006 Jun; 27(6):495-9. PubMed ID: 16710103
[TBL] [Abstract][Full Text] [Related]
6. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
[TBL] [Abstract][Full Text] [Related]
7. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
Lee SM; Lee JW; Kim SY; Han SW; Bae WK
Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
[TBL] [Abstract][Full Text] [Related]
8. Effects of postoperative antioxidants on the salivary glands in patients with thyroid cancer undergoing radioactive iodine-131 treatment.
Tong H; Yue R; Fang J; Li X; Yang S; Hou Y; Wang R; Zhang B; Liu H; Wu Z; Cheng Y
Nucl Med Commun; 2024 Apr; 45(4):312-320. PubMed ID: 38312062
[TBL] [Abstract][Full Text] [Related]
9. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland function in thyroid cancer patients with radioiodine administration history.
Krcalova E; Horacek J; Gabalec F; Zak P; Dolezal J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):277-283. PubMed ID: 31223135
[TBL] [Abstract][Full Text] [Related]
11. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
Wu JQ; Feng HJ; Ouyang W; Sun YG; Chen P; Wang J; Xian JL; Huang LH
Nucl Med Commun; 2015 Aug; 36(8):819-26. PubMed ID: 25932534
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin E and supragingival scaling on salivary gland function in patients with differentiated thyroid cancer treated with 131I.
Cheng Y; Tong H; Li X; Zhang X; Fang J; Yue R; Huang N; Tian J; Yu F; Gao Y
Nucl Med Commun; 2022 Sep; 43(9):995-1003. PubMed ID: 35950355
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy].
Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Kalina S; Clausen M; Henze E
Nuklearmedizin; 1997 Apr; 36(3):103-9. PubMed ID: 9162904
[TBL] [Abstract][Full Text] [Related]
14. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the success of thyroid remnant ablation using preablative 99mTc pertechnetate scintigraphy and postablative dual 131I scintigraphy.
Jung JS; Lee SM; Kim SJ; Choi J; Han SW
Nucl Med Commun; 2015 Jan; 36(1):38-44. PubMed ID: 25299469
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
Caglar M; Tuncel M; Alpar R
Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
[TBL] [Abstract][Full Text] [Related]
17. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine.
Malpani BL; Samuel AM; Ray S
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):535-40. PubMed ID: 8655377
[TBL] [Abstract][Full Text] [Related]
18. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?
Fallahi B; Beiki D; Abedi SM; Saghari M; Fard-Esfahani A; Akhzari F; Mokarami B; Eftekhari M
Nucl Med Commun; 2013 Aug; 34(8):777-86. PubMed ID: 23708871
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
20. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
